Long Wharf Investors’s GSK GSK Stock Holding History

Long Wharf Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$3.85M	Hold	57,532	–	–	3.02%	2
2014 Q1	$3.84M	Hold	57,532	–	–	3.29%	2
2013 Q4	$3.84M	Hold	57,532	–	–	3.48%	2
2013 Q3	$3.61M	Sell	57,532 -80	-0.1%	-$5.15K	3.44%	2
2013 Q2	$3.6M	Buy	+57,612	New	+$3.66M	3.54%	3

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Long Wharf Investors's GSK Position: Q2 2014 in Review

Long Wharf Investors held its GSK (GSK) position steady in Q2 2014 at 57,532 shares worth $3.85M. The position accounts for 3.02% of the portfolio, ranked #2.

Long Wharf Investors first reported a position in GSK in Q2 2013 and has held it in 5 quarters since. 723 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

Long Wharf Investors held 57,532 shares of GSK worth $3.85M as of Q2 2014.
Long Wharf Investors left its GSK share count unchanged in Q2 2014.
GSK made up 3.02% of Long Wharf Investors's portfolio in Q2 2014, its #2 holding.
Long Wharf Investors first reported a position in GSK in Q2 2013 and has held it in 5 quarters since.
723 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on Long Wharf Investors's 13F filing for Q2 2014, filed 4 Aug 2014.